Pharmacogenomics and Pharmacogenetics

Pharmacogenomics and Pharmacogenetics Photo
Pharmacogenomics is the study of how genes affect a person’s response to drugs. This relatively new field combines pharmacology (the science of drugs) and genomics (the study of genes and their functions) to develop effective, safe medications and doses that will be tailored to a person’s genetic makeup. The field of pharmacogenomics is still in its infancy. Its use is currently quite limited, but new approaches are under study in clinical trials. In the future, pharmacogenomics will allow the development of tailored drugs to treat a wide range of health problems, including cardiovascular disease, Alzheimer disease, cancer, HIV/AIDS, and asthma. Pharmacogenetics is the study of inherited genetic differences in drug metabolic pathways which can affect individual responses to drugs, both in terms of therapeutic effect as well as adverse effects. In oncology, pharmacogenetics historically is the study of germline mutations (e.g., single-nucleotide polymorphisms and pharmacokinetics. Another newfound use of pharmacogenetics involves the use of Vitamin E to lower the risk of cardiovascular disease in patients with diabetes.

Are you interested in

Mail us at

General Enquiries
geneexpression@outlook.com
More details about sponsorship:sponsors@alliedacademies.com
Copyright © 2017-2018 Allied Academies, All Rights Reserved.